Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hammond

Showing results (571-580 of 711) with videos related to

Pageof 72
Sort By:
Social Science & Medicine (1982)|June 28, 2021
From causal loop diagrams to future scenarios: Using the cross-impact balance method to augment understanding of urban health in Latin AmericaIvana Stankov, Andres Felipe Useche, Jose D Meisel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignanciesQuincy Siu-Chung Chu, Lisa A Hammond, Garry Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasmsLisa A Hammond, John R Eckardt, John G Kuhn, et al.
Lancet (London, England)|February 24, 2015
Mobilisation of public support for policy actions to prevent obesityTerry T-K Huang, John H Cawley, Marice Ashe, et al.
Bone|July 13, 2019
Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosingElizabeth A Swallow, Mohammad W Aref, Corinne E Metzger, et al.
Journal of Critical Care|March 3, 2018
Major publications in the critical care pharmacotherapy literature: January-December 2017Drayton A Hammond, Laura Baumgartner, Craig Cooper, et al.
BMC Public Health|June 2, 2018
Development and testing of a novel survey to assess Stakeholder-driven Community Diffusion of childhood obesity prevention effortsAriella R Korn, Erin Hennessy, Ross A Hammond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumorsAmita Patnaik, Debra Wood, Anthony W Tolcher, et al.
Methodsx|September 24, 2021
Using cause-effect graphs to elicit expert knowledge for cross-impact balance analysisIvana Stankov, Andres F Useche, Jose D Meisel, et al.
Journal of Critical Care|May 18, 2019
Major publications in critical care pharmacotherapy literature in 2018Andrea Sikora Newsome, Brittany D Bissell, Lisa D Burry, et al.
Pageof 72

Showing results (571-580 of 711) with videos related to

Sort By:
Pageof 72
Social Science & Medicine (1982)|June 28, 2021
From causal loop diagrams to future scenarios: Using the cross-impact balance method to augment understanding of urban health in Latin AmericaIvana Stankov, Andres Felipe Useche, Jose D Meisel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignanciesQuincy Siu-Chung Chu, Lisa A Hammond, Garry Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasmsLisa A Hammond, John R Eckardt, John G Kuhn, et al.
Lancet (London, England)|February 24, 2015
Mobilisation of public support for policy actions to prevent obesityTerry T-K Huang, John H Cawley, Marice Ashe, et al.
Bone|July 13, 2019
Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosingElizabeth A Swallow, Mohammad W Aref, Corinne E Metzger, et al.
Journal of Critical Care|March 3, 2018
Major publications in the critical care pharmacotherapy literature: January-December 2017Drayton A Hammond, Laura Baumgartner, Craig Cooper, et al.
BMC Public Health|June 2, 2018
Development and testing of a novel survey to assess Stakeholder-driven Community Diffusion of childhood obesity prevention effortsAriella R Korn, Erin Hennessy, Ross A Hammond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumorsAmita Patnaik, Debra Wood, Anthony W Tolcher, et al.
Methodsx|September 24, 2021
Using cause-effect graphs to elicit expert knowledge for cross-impact balance analysisIvana Stankov, Andres F Useche, Jose D Meisel, et al.
Journal of Critical Care|May 18, 2019
Major publications in critical care pharmacotherapy literature in 2018Andrea Sikora Newsome, Brittany D Bissell, Lisa D Burry, et al.
Pageof 72